| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 7,000 | 0 | 0 | 7,000 |
| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
TEL AVIV SOURASKY MEDICAL CENTER |
WEIZMANN ST 6 TEL AVIVYAFO 6423906 IS |
2023-02-27 | 276,000 | PROJECT: THE ROLE OF THE IMMUNE SYSTEM IN GLUOCEREBROSIDASE (GBA)-PD: A CSF AND PBMC STUDY | 276,000 | NO | 11/1/2024 | 2025-09-15 | FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) |
|
SUNNYBROOK RESEARCH INSTITUTE |
2075 BAYVIEW AVENUE TORONTO,ONTARIOM4N 3M5 CA |
2023-02-22 | 250,000 | PROJECT: A PHASE I/II STUDY FOR BILATERAL PUTAMENAL DELIVERY OF RECOMBINANT GLUCOCEREBROSIDASE IN PATIENTS WITH PARKINSONS DISEASE USING MR-GUIDED FOCUSED ULTRASOUND INDUCED OPENING OF THE BLOOD-BRAIN BARRIER | 250,000 | NO | 2/22/2024 | 2025-09-15 | FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) |
|
HAMAD BIN KHALIFA UNIVERSITY |
EDUCATION CITY - GATE 8 ARRAYYAN 00000 QA |
2023-08-29 | 190,000 | PROJECT: THERAPEUTIC NANOBODY DEVELOPMENT FOR TARGETING ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE, WITH FOCUS ON PARKINSON'S DISEASE WITH GBA MUTATION | 190,000 | NO | 10/1/2024 | 2025-09-15 | FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) |
|
CURASEN THERAPEUTICS INC |
930 BRITTAN AVENUE SUITE 306 SAN CARLOS,CA94070 |
2023-01-03 | 225,000 | PROJECT: GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY | 225,000 | NO | 2/26/2024 | 2025-09-15 | FUNDS USED IN LINE WITH IRC SECTION 170(C)(2)(B) |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 3,694 | 0 | 0 | 3,694 |
| Description | Amount |
|---|---|
| UNREALIZED (GAIN) / LOSS | 5,411 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| SOFTWARE LICENSE AND SUPPORT | 3,171 | 0 | 0 | 3,171 |
| OTHER EXPENSE | 10,002 | 2 | 0 | 10,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OTHER PROFESSIONAL FEES | 1,092 | 0 | 0 | 1,092 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAXES UNDER SECTION 4940 | 848 | 0 | 0 | 0 |